Printer Friendly

Browse Psoriasis topic

Drug therapy subtopic

Articles

1-281 out of 281 article(s)
Title Author Type Date Words
Novartis treatment for juvenile idiopathic arthritis meets endpoint. Jun 2, 2021 228
Arcutis Biotherapeutics presents roflumilast safety, efficacy data. Apr 23, 2021 747
AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency. Apr 8, 2021 251
AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency. Apr 8, 2021 250
Amgen submits US FDA supplemental New Drug Application for Otezla. Feb 23, 2021 217
Amgen submits US FDA supplemental New Drug Application for Otezla. Feb 23, 2021 221
A review on updates in management and Treatment of Psoriasis. Alhammad, Ibtihal Mohammed; Aseri, Amal Mohammed; Alqahtani, Sultan Ali M.; Alshaebi, Malak Fuad; Al Report Jan 1, 2021 3694
Pregnancy studies on psoriasis, PsA medications pick up. Kilgore, Christine Medical condition overview Dec 1, 2020 1411
SAFETY DATA: Pregnancy studies on psoriasis, PsA medications pick up. Kilgore, Christine Medical condition overview Nov 1, 2020 1442
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis. Olabi, Bayanne; Ayob, Shanti Aug 31, 2020 1114
Investigation on the Mechanism of Qubi Formula in Treating Psoriasis Based on Network Pharmacology. Zhou, Lin; Zhang, Lingyun; Tao, Disheng Jul 31, 2020 8429
Cutaneous Effects of Notch Inhibitor Therapy: A Report of Two Cases. Wiggins, Claire J.; Chon, Susan Y. Jul 31, 2020 2478
Mylan Gets OK for Biosimilar to Humira. Jul 27, 2020 205
Mylan and Fujifilm Kyowa Kirin partnership receives FDA approval for arthritis treatment Hulio. Jul 10, 2020 186
US FDA approves Mylan and Fujifilm Kyowa Kirin Biologics' Hulio. Jul 10, 2020 190
US FDA approves Mylan and Fujifilm Kyowa Kirin Biologics' Hulio. Jul 10, 2020 194
Mylan and Fujifilm Kyowa Kirin partnership receives FDA approval for arthritis treatment Hulio. Jul 10, 2020 190
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis. Jul 8, 2020 252
AAD-NPF releases first new guidelines for nonbiologic systemic treatments of psoriasis in over a decade. Kirkner, Richard Mark Apr 1, 2020 1135
Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study. Carlet, Clementine; Bichard, Damien; Richard, Marie Aleth; Mahe, Emmanuel; Saillard, Ciemence; Brena Mar 31, 2020 2051
Big boost for autoimmune disease treatment in the UAE. Staff Report Jan 4, 2020 348
Amgen Gets Regulatory Approval For Arthritis, Crohn's Disease Drug. Dec 9, 2019 158
United States Food and Drug Administration approves Pfizer's ABRILADA. Nov 20, 2019 213
United States Food and Drug Administration approves Pfizer's ABRILADA. Nov 20, 2019 209
US FDA Approves Pfizer's Biosimilar, Abrilada for Multiple Inflammatory Conditions. Nov 19, 2019 750
Global Psoriasis Drugs Market Report 2019-2020. Report Nov 7, 2019 835
AAD, NPF release two joint guidelines on treatment, management of psoriasis. Craven, Jeff Oct 1, 2019 1376
EULAR keeps csDMARDs as top PsA drugs. Zoler, Mitchel L. Oct 1, 2019 1086
Systemic psoriasis treatments less often prescribed in elderly with psoriasis, despite comparable response rates. Bowser, Andrew D. Oct 1, 2019 732
Drug for treating psoriasis can be used to treat malaria, finds study. Sep 19, 2019 523
Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis. Kisaarslan, Aysenur Pac; Sozeri, Betul; Gunduz, Zubeyde; Zararsiz, Gokmen; Poyrazoglu, Hakan; Dusuns Sep 1, 2019 4297
Lilly's Ankylosing Spondylitis drug Taltz(R) (ixekizumab) receives US FDA approval. Aug 27, 2019 216
Lilly's Ankylosing Spondylitis drug Taltz(R) (ixekizumab) receives US FDA approval. Aug 27, 2019 212
Eli Lilly & Company (NYSE: LLY) - Lilly Receives U.S. FDA Approval for Taltz[R] (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) -- 26/8/2019. Aug 27, 2019 719
Eli Lilly announces FDA approval of Taltz for third indication of AS treatment. Aug 26, 2019 155
SIU School of Medicine holding psoriasis clinical trial. Aug 23, 2019 131
Lilly's Psoriasis Drug Found Superior To J&J's Tremfya In Phase 4 Study. Aug 13, 2019 371
What is the key outcomes analysis of the Global Dermatology Drugs Market? Players evolve: Pfizer, Amgen, Novartis, Bayer, Johnson & Johnson. Aug 9, 2019 1089
Leo Pharma Wins US Food and Drug Administration Expanded Regulatory Approvals for Enstilar Foam and Taclonex Topical Suspension in Treatment of Plaque Psoriasis. Aug 2, 2019 373
Janssen Presents New Real-World Evidence Which Suggests that Effective PsA Treatment Should Target More than Skin and Joints. Jun 17, 2019 860
Herpes zoster risk increased with some psoriasis, PsA treatments. Nogrady, Bianca May 1, 2019 469
AbbVie wins US FDA clearance for SKYRIZI to treart moderate to severe plaque psoriasis in adults. Apr 24, 2019 299
AbbVie wins US FDA clearance for SKYRIZI to treart moderate to severe plaque psoriasis in adults. Apr 24, 2019 295
AbbVie says FDA approves SKYRIZI. Apr 23, 2019 165
A COMPARATIVE STUDY OF ONCE DAILY TAZAROTENE VERSUS COMBINATION OF TAZAROTENE AND BETAMETHASONE VALERATE IN THE TREATMENT OF PLAQUE PSORIASIS. Report Mar 31, 2019 3510
AbbVie passes MHLW approval for SKYRIZI for the treatment of psoriasis in Japan. Mar 26, 2019 297
AbbVie passes MHLW approval for SKYRIZI for the treatment of psoriasis in Japan. Mar 26, 2019 293
Study links psoriasis treatment and improvement in heart artery disease. Mar 1, 2019 289
Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. Kutluk, Oznur; Enginar, Ayse Unal; Balci, Nilufer; Butun, Bulent; Kacar, Cahit Mar 1, 2019 2304
Algorithm addresses TNF inhibitor-induced psoriasis. Craven, Jeff Drug overview Feb 1, 2019 744
EFFECTIVENESS OF CALCIPOTRIOL VERSUS BETAMETHASONE DIPROPIONATE IN THE TREATMENT OF MILD TO MODERATE CHRONIC PLAQUE PSORIASIS. Report Dec 31, 2018 1415
Janssen Pharmaceutical's psoriasis drug achieves primary endpoint in phase 3 trial. Dec 14, 2018 173
Janssen Pharmaceutical's psoriasis drug achieves primary endpoint in phase 3 trial. Dec 14, 2018 169
US FDA grants approval to Sandoz's Hyrimoz. Nov 1, 2018 136
US FDA grants approval to Sandoz's Hyrimoz. Nov 1, 2018 132
Adalimumab safety update finds no new signals. Palmer, Christopher Brief article Nov 1, 2018 299
Novartis' Sandoz announces FDA approval for biosimilar Hyrimoz. Oct 31, 2018 103
Halobetasol Propionate Lotion Shows Efficacy for Tx of Psoriasis; Findings based on two phase 3 trials of halobetasol propionate lotion versus vehicle. Oct 10, 2018 268
Medication app boosts psoriasis patients' short-term adherence. Splete, Heidi Oct 1, 2018 654
Topical corticosteroid-retinoid combination effective in moderate to severe psoriasis. Nogrady, Bianca Oct 1, 2018 678
FDA Accepts Resubmission of New Drug Application for Duobrii Lotion. Aug 30, 2018 179
Ortho Dermatologics Resubmits US New Drug Application for DuobrII Lotion. Aug 17, 2018 235
Ortho Dermatologics resubmits DUOBRII's NDA with US FDA. Aug 16, 2018 173
Ortho Dermatologics resubmits DUOBRII's NDA with US FDA. Aug 16, 2018 169
HIGHLIGHTS OF Skin Disease Education Foundation's 42nd Annual Hawaii Dermatology Seminar[R] Grand Hyatt Kauai, Hawaii; February 4-9, 2018. Baldwin, Hilary E.; Gold, Linda F. Stein; Gordon, Kenneth B.; Green, Jeremy B.; Leonardi, Craig L.; Jul 1, 2018 11930
FDA Approval of Cimzia (certolizumab pegol) Presents New Treatment Options for Plaque Psoriasis. May 31, 2018 282
AbbVie Seeks European Marketing Authorisation for Risankizumab for Treatment of Plaque Psoriasis. May 4, 2018 228
Encore Dermatology Launches Impoyz (clobetasol propionate) Cream, 0.025%. May 3, 2018 176
Phone App Linked to Improved Psoriasis Treatment Adherence; App intervention group also had greater reduction in psoriasis severity than non-intervention group. Apr 23, 2018 194
Ortho Dermatologics Publishes Efficacy and Safety Data For Psoriasis Treatment Duobrii in Journal of the American Academy of Dermatology. Apr 11, 2018 172
New Treatment Paradigms in Psoriasis: Understanding and incorporating Recent and Emerging Trends Post-Test. Apr 1, 2018 594
The US FDA approves Sun Pharma's plaque psoriasis drug Ilumya. Mar 23, 2018 277
The US FDA approves Sun Pharma's plaque psoriasis drug Ilumya. Mar 23, 2018 273
AbbVie and Eisai Obtain Additional Approval for New Indication of Fully Human Anti-TNF-alpha Monoclonal. Mar 23, 2018 740
Sun Pharma wins US FDA approval for ILUMYA (tildrakizumab-asmn) for the treatment of Plaque Psoriasis. Mar 22, 2018 227
Sun Pharma wins US FDA approval for ILUMYA (tildrakizumab-asmn) for the treatment of Plaque Psoriasis. Mar 22, 2018 223
Novartis' scalp psoriasis drug improves skin clearance in phase III scalp study. Feb 20, 2018 246
Novartis' scalp psoriasis drug improves skin clearance in phase III scalp study. Feb 20, 2018 242
US FDA Accepts Ortho Dermatologics Filing for Jemdel Plaque Psoriasis Treatment. Feb 20, 2018 186
Avillion Opens IND for Phase 2 Study of Anti-IL-17 A/F Nanobody for treatment of Psoriasis. Feb 20, 2018 316
Novartis says psoriasis drug study shows improved quality of life over 5 years. Clinical report Feb 16, 2018 212
Comparing the Efficacy of Triamcinolone Acetonide Iontophoresis versus Topical Calcipotriol/Betamethasone Dipropionate in Treating Nail Psoriasis: A Bilateral Controlled Clinical Trial. Saki, Nasrin; Hosseinpoor, Shahla; Heiran, Alireza; Mohammadi, Ali; Zeraatpishe, Mehdi Report Jan 1, 2018 4041
AbbVie meets primary endpoints in two phases of fourth phase three clinical trial of psoriasis drug. Dec 6, 2017 249
AbbVie meets primary endpoints in two phases of fourth phase three clinical trial of psoriasis drug. Dec 6, 2017 245
Janssen launches plaque psoriasis treatment in UK. Nov 24, 2017 194
Janssen launches plaque psoriasis treatment in UK. Nov 24, 2017 190
Pediatric psoriasis: Fewer side effects with TNF inhibitors than with MIX. Cheslow, Erin Drug overview Nov 1, 2017 555
US FDA Approves Stelara (ustekinumab) For Treatment of Adolescents with Moderate to Severe Plaque Psoriasis. Oct 18, 2017 334
Ixekizumab proves highly effective for palmoplantar, scalp psoriasis. Jancin, Bruce Oct 1, 2017 1084
Mideast conf. presents new Psoriasis treatment. Sep 21, 2017 129
Valeant Pharmaceuticals Division Submits NDA to FDA for IDP-118 Topical Lotion for Treatment of Plaque Psoriasis. Sep 6, 2017 409
NICE recommends new treatment option for psoriasis. Aug 7, 2017 258
FDA approves IL-23 blocker, guselkumab, for psoriasis. Mechcatie, Elizabeth Aug 1, 2017 306
Emerging therapies for the systemic treatment of psoriasis. Gordon, Kenneth B.; Leonardi, Craig L. Disease/Disorder overview Aug 1, 2017 1932
Treatment of rheumatoid arthritis with biological agents --as a typical and common immune-mediated inflammatory disease. Takeuchi, Tsutomu Report Aug 1, 2017 4614
NICE approves three drugs treating plaque psoriasis in children. Jul 13, 2017 252
NICE approves three drugs treating plaque psoriasis in children. Jul 13, 2017 248
The potential role of inhibitory receptors in the treatment of psoriasis. Shah, Nehal; Sandigursky, Sabina; Mor, Adam Jul 1, 2017 6983
Samsung Bioepis gains first U.S. FDA approval. May 1, 2017 225
Importance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab. Mota, Fernando; Neves, Esmeralda; Oliveira, Jose Carlos; Selores, Manuela; Torres, Tiago Report Apr 1, 2017 1889
EFFICACY AND SAFETY OF METHOTREXATE VERSUS ACITRETIN IN CHRONIC PLAQUE PSORIASIS. Report Mar 31, 2017 2949
Abbvie's HUMIRA gains US FDA approval to treat moderate to severe fingernail psoriasis. Mar 31, 2017 248
Abbvie's HUMIRA gains US FDA approval to treat moderate to severe fingernail psoriasis. Mar 31, 2017 244
Novartis hails success of its psoriasis treatment drug Cosentyx. Mar 21, 2017 293
Novartis hails success of its psoriasis treatment drug Cosentyx. Mar 21, 2017 289
Janssen psoriasis drug successful in phase III trials. Mar 6, 2017 248
Janssen psoriasis drug successful in phase III trials. Mar 6, 2017 244
US FDA Approves Valeant's Siliq (Brodalumab) for Plaque Psoriasis. Feb 21, 2017 527
Valeant wins US FDA approval for SILIQ for the treatment of plaque psoriasis. Feb 17, 2017 288
Valeant wins US FDA approval for SILIQ for the treatment of plaque psoriasis. Feb 17, 2017 284
US FDA Approves New Psoriasis Drug from Valeant. Feb 17, 2017 506
Ixekizumab found effective for scalp, palmoplantar disease. Jancin, Bruce Feb 1, 2017 772
Janssen Biotech. Jan 1, 2017 144
Comparison of efficacy of calcipotriol and betamethasone combination with betamethasone alone in plaque psoriasis. Singh, Harish Sardar; Narayana, Sarala; Vijayarangam, Shivakumar Jan 1, 2017 2280
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab. Ghoneim, Sara; Ramos-Rodriguez, Alvaro J.; de Lara, Fernando Vazquez; Bonomo, Lauren Case study Jan 1, 2017 1988
AbbVie receives Orphan Drug Designation from US FDA for risankizumab. Dec 2, 2016 213
AbbVie receives Orphan Drug Designation from US FDA for risankizumab. Dec 2, 2016 209
Cardiovascular medicine. Dec 1, 2016 484
Consider comorbidities in psoriasis treatment for better outcomes. McKnight, Whitney Nov 1, 2016 464
New psoriasis drug available on Welsh NHS. Oct 21, 2016 138
Sandoz' Erelzi gets approval from the FDA. Sep 26, 2016 404
Update on TNF inhibitors in dermatology. Sobell, Jeffrey M. Sep 1, 2016 2585
Update on TNF inhibitors. Kerdel, Francisco A. Aug 1, 2016 4242
Why biologic therapies sometimes lose efficacy. Strober, Bruce E. Aug 1, 2016 2383
QU teams up with Italian varsity for psoriasis treatment research. Jul 23, 2016 278
AbbVie presents data from pivotal phase-3 fingernail psoriasis medication trial at Psoriasis 2016 Congress. Clinical report Jul 8, 2016 212
AbbVie presents data from pivotal phase-3 fingernail psoriasis medication trial at Psoriasis 2016 Congress. Clinical report Jul 8, 2016 208
TNF blocker safety may differ In RA, psoriasis patients. Splete, Heidi Jul 1, 2016 412
Dr Reddy's Laboratories unveils Sernivo (betamethasone dipropionate) Spray, 0.05% for plaque psoriasis patients across the US. Jun 1, 2016 210
Dr Reddy's Laboratories unveils Sernivo (betamethasone dipropionate) Spray, 0.05% for plaque psoriasis patients across the US. Jun 1, 2016 206
Eli Lilly and Company introduces Taltz injection 80 mg/ml for treating moderate-to-severe plaque psoriasis in the US. May 3, 2016 236
Eli Lilly and Company introduces Taltz injection 80 mg/ml for treating moderate-to-severe plaque psoriasis in the US. May 3, 2016 232
LEO Pharma receives EU scientific approval for psoriasis drug Enstilar. Mar 23, 2016 230
LEO Pharma receives EU scientific approval for psoriasis drug Enstilar. Mar 23, 2016 226
Eli Lilly and Company passes the US FDA's approval for Taltz (ixekizumab) injection 80 mg/ml for treating severe plaque psoriasis in adult patients. Mar 23, 2016 276
Eli Lilly and Company passes the US FDA's approval for Taltz (ixekizumab) injection 80 mg/ml for treating severe plaque psoriasis in adult patients. Mar 23, 2016 272
Leo Pharma Receives Scientific Approval in Europe for Enstilar as Psoriasis Treatment. Mar 21, 2016 297
Leo Pharma Receives Scientific Approval in Europe for Enstilar as Psoriasis Treatment. Mar 21, 2016 266
Potential biomarker for psoriasis severity, treatment efficacy. Goodman, Alice Mar 1, 2016 326
PsoriFix LLC Has Manufactured a New Psoriasis Treatment Cream. Feb 25, 2016 233
New oral psoriasis drug shows excellent safety: planning is underway for a pivotal phase III trial of CF101 in psoriasis. Jancin, Bruce Feb 1, 2016 645
Nutritional profile and consumption of inflammatory and anti-inflammatory foods by patients treated in a psoriasis outpatient clinic of a health-school unit in Itajai, SC, Brazil. Odierno, Katarine de Faria; Coelho, Bruna Elisa Harmel de Borba; de Matos, Cristina Henschel Dec 1, 2015 4764
UAE one of earliest to have psoriasis medication. Sep 10, 2015 394
Recognizing guttate psoriasis and initiating appropriate treatment. Vence, Lacey; Schmitt, Amanda; Meadows, Charles E.; Gress, Todd Report Jul 1, 2015 1490
New Drug To Treat Psoriasis. Jun 22, 2015 342
Systemic treatment eased enthesitis in psoriasis. Chitnis, Deepak Clinical report Jun 1, 2015 426
An open label prospective randomized trial to compare the efficacy of salicylic acid ointment 3% versus betamethasone dipropionate ointment in the treatment of limited chronic plaque psoriasis. Bai, K. Santha; Naik, P. Sreenivas May 4, 2015 2332
CLEAR trial results favor secukinumab for psoriasis. Karon, Amy Report May 1, 2015 471
Severe hepatic toxicity after administration of infliximab in psoriasis treatment. Chiriac, Oana Gabriela; Trifan, Anca; Singeap, Ana Maria; Cojocariu, Camelia; Stanciu, Carol; Sfarti Clinical report Dec 1, 2014 2125
Living with psoriasis TREATMENTS; Agony of thousands who suffer pain and a loss of confidence from skin condition. Oct 15, 2014 708
Celgene wins US FDA's approval for OTEZLA for the treatment of patients with moderate to severe plaque psoriasis. Sep 24, 2014 226
Celgene wins US FDA's approval for OTEZLA for the treatment of patients with moderate to severe plaque psoriasis. Sep 24, 2014 222
Boswellia cream may help treat psoriasis. Sep 1, 2014 273
Boswellia cream may help treat psoriasis. Sep 1, 2014 273
The exacerbation of cutaneous psoriasis induced by anti--TNF therapy--case report. Costache, Anca; Chiriac, Madalina Ionela; Rezus, Elena Clinical report Jun 1, 2014 1775
Perrigo announces first shipment of approved generic Taclonex Ointment for the topical treatment of plaque psoriasis. Apr 2, 2014 135
Perrigo announces first shipment of approved generic Taclonex Ointment for the topical treatment of plaque psoriasis. Apr 2, 2014 131
Management of moderate to severe plaque psoriasis in pregnancy and lactation in the era of biologies. Mervic, Liljana Report Apr 1, 2014 4670
Celgene wins US FDA's approval for OTEZLA. Mar 24, 2014 246
Celgene wins US FDA's approval for OTEZLA. Mar 24, 2014 242
Investigational treatments for psoriasis: oral molecules being tested as topicals. Smith, Jennie Mar 1, 2014 424
A case of inverse psoriasis successfully treated with adalimumab. Jese, Rok; Perdan-Pirkmajer, Katja; Dolenc-Voljc, Mateja; Tomsic, Matija Clinical report Mar 1, 2014 1148
Comparative safety of topical calcipotriol (0.005%) versus topical corticosteroid (betamethasone 0.1%) in plaque type psoriasis. Report Dec 31, 2013 3455
Efficacy and safety of simvastatin in chronic plaque psoriasis. Aslam, Shazia; Khurshid, Khawar; Asad, Faria; Rani, Zahida; Pal, Sabrina Suhail Report Sep 30, 2013 2159
Skin drug may hold key to type 1 diabetes treatment. Sep 23, 2013 197
Expertise in skin care one way to build shopper loyalty. Johnston, Jennifer Aug 19, 2013 471
Cellceutix Corporation to commence clinical study of anti-psoriasis drug Prurisol and upgrade to national securities exchange. Aug 13, 2013 167
Cellceutix Corporation to commence clinical study of anti-psoriasis drug Prurisol and upgrade to national securities exchange. Aug 13, 2013 163
Summer sun 'natural medication' for psoriasis sufferers. Aug 12, 2013 184
Azathioprine pulse therapy in the treatment of psoriasis. Report Jun 30, 2013 2364
Psoralen-ultraviolet a treatment with Psoralen-ultraviolet B therapy in the treatment of psoriasis. Jun 30, 2013 2325
Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Brief article May 1, 2013 102
Topical herbal medicine for psoriasis. Report Jan 1, 2013 394
Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches. Colombo, M.D.; Cassano, N.; Bellia, G.; Vena, G.A. Report Jan 1, 2013 9446
COMPARATIVE EFFICACY OF TWICE WEEKLY VERSUS THRICE WEEKLY NARROW BAND UVB PHOTOTHERAPY IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS. Clinical report Dec 31, 2012 2701
Psoriasis drugs may help 'slow dementia'. Nov 26, 2012 390
Oral MS drug performs well: medication similar to one now used against psoriasis. Seppa, Nathan Oct 20, 2012 534
Role of hydroxyurea in psoriasis - a review. Khondker, Lubna; Choudhury, Agha Masood; Shah, Md Obaidur Rahman; Shahidullah, Md; Khan, Md Shirajul Report Sep 30, 2012 1766
Perrigo Company unveils US FDA approved Clobetasol Propionate Shampoo, 0.05% for scalp psoriasis. Aug 10, 2012 132
Perrigo Company unveils US FDA approved Clobetasol Propionate Shampoo, 0.05% for scalp psoriasis. Aug 10, 2012 128
Psoriasis drugs fall short in real-world settings. Jancin, Bruce Clinical report Aug 1, 2012 561
New psoriasis drug reduces vessel inflammation. Wachter, Kerri Apr 15, 2012 687
New psoriasis treatment can cut risk of heart attack and stroke. Mar 17, 2012 371
Cellceutix Corporation files pre-IND documentation with FDA for new psoriasis drug Prurisol. Mar 13, 2012 157
Foundation takes bold approach to psoriasis: new National Psoriasis Foundation guidelines focus on managing the disease beyond the topical level. Wendling, Patrice Mar 1, 2012 1197
Early treatment aids quality of life in psoriasis. Splete, Heidi Feb 15, 2012 536
FDA approves Phase II trial of Idera's IMO-3100 in psoriasis patients. Dec 2, 2011 119
Biotest says Phase II study of Tregalizumab confirms efficacy in chronic plaque proriasis. Clinical report Nov 24, 2011 291
New-onset palmoplantar psoriasis during treatment of active Ankylosing spondylitis with TNF-alpha blocking agent adalimumab / TNF-alfa bloke edici ajan adalimumabla yurutulen aktif ankilozan spondilit tedavisi sirasinda meydana gelen yeni baslangicli palmoplantar psoriyazis. Akgul, Ozgur; Calis, Mustafa; Ozgocmen, Salih Disease/Disorder overview Sep 1, 2011 1006
Psoriatic arthritis: treatment update. Mease, Philip J. Jul 1, 2011 5153
Drugs for rheumatoid arthritis, psoriasis may cut diabetes risk. Jun 22, 2011 256
Clobex/Vectical combo effective for psoriasis. Jun 15, 2011 348
Common drug for leukemia, psoriasis may fight vascular disease. May 28, 2011 225
What's coming down the psoriasis Tx pipeline. Jancin, Bruce Mar 15, 2011 567
Psoriasis drug may help in the fight against multiple sclerosis. Mar 9, 2011 327
Trial clarifies methotrexate dosing in psoriasis. Jancin, Bruce Report Nov 15, 2010 640
Role of oral colchicine in plaque type psoriasis. A randomized clinical trial comparing with oral methotrexate. Report Sep 30, 2010 2630
Comparison of methotrexate and azathioprine in the treatment of psoriasis: a randomized controlled trial. Report Sep 30, 2010 2825
Comparison was long overdue. Blauvelt, Andrew Brief article Feb 1, 2010 198
Are there any new psoriasis medicines? Dec 6, 2009 692
Provectus reports preliminary Phase II data for PH-10 for treatment of psoriasis, atopic dermatitis. Dec 1, 2009 305
Turmeric may help offer treatments for colon cancer, psoriasis, Alzheimer's. Nov 5, 2009 217
TNF blocker warning strengthened. Sep 1, 2009 209
PML risk drives efalizumab off the market for psoriasis. Napoli, Denise Report May 1, 2009 336
Ustekinumab beats etanercept for psoriasis. Jancin, Bruce Brief article Apr 15, 2009 265
FDA approves new vitamin D topical for plaque psoriasis. McNamara, Damian Apr 1, 2009 466
Patients dropping efalizumab face rebound. Jancin, Bruce Report Apr 1, 2009 629
Think efficacy, toxicity when treating psoriasis. Wachter, Kerri Feb 15, 2009 567
DM to open new office in Bada Workshop on intravenous treatment of psoriasis. Feb 8, 2009 157
DM to open new office in Bada Workshop on intravenous treatment of psoriasis. Feb 8, 2009 155
Indigo ointment may harbour safe and effective psoriasis cure. Dec 3, 2008 267
Think efficacy and toxicity in selecting psoriasis medications. Wachter, Kerri Dec 1, 2008 599
Indigo ointment may harbour safe and effective psoriasis cure. Nov 25, 2008 267
Safety concerns and labeling changes for psoriasis drug Raptiva. Nov 1, 2008 248
Triamcinolone 10 mg is best for psoriatic nails. Wendling, Patrice Brief article Oct 1, 2008 213
Infliximab safe for pustular psoriasis. Worcester, Sharon Clinical report Aug 1, 2008 355
Alefacept still useful in psoriasis; 1 in 9 remit. Jancin, Bruce Jul 15, 2008 417
Humira. Mechcatie, Elizabeth; McNamara, Damian Drug overview Mar 1, 2008 444
Topical betamethasone in the treatment of chronic plaque psoriasis: a review. Prasutr, Thawornchaisit Clinical report Mar 1, 2008 4305
Topical coal tar preparations in the treatment of chronic plaque psoriasis: a review. Prasutr, Thawornchaisit Mar 1, 2008 2359
Psoriasis drug excels in phase III study. Finn, Robert Clinical report Feb 15, 2008 410
Report compares drugs for two types of arthritis. Brunk, Doug Feb 15, 2008 884
MEDIMMUNE STARTS PHASE I TRIAL FOR PSORIASIS TREATMENT. May 1, 2007 786
Biologics showing efficacy for psoriasis. Boschert, Sherry Apr 1, 2007 760
Extended efalizumab for psoriasis well tolerated. Boschert, Sherry May 15, 2006 571
New psoriasis drugs may boost compliance. Jancin, Bruce May 15, 2006 661
Psoriasis drug shows 'stunning' early promise. MacNeil, Jane Salodof Mar 1, 2006 648
Future psoriasis drugs may target role of dendritic cells. McNamara, Damian Mar 1, 2006 402
FDA approves once-daily topical combo of steroid, vitamin D for psoriasis Tx. Johnson, Kate Brief article Mar 1, 2006 313
FDA approves topical combo of steroid, vitamin D for psoriasis. Johnson, Kate Brief Article Feb 15, 2006 312
Derm drug interactions: top ten to watch for. Walsh, Nancy Feb 1, 2006 921
Drug combo effective in psoriatic arthritis. Wendling, Patrice Dec 15, 2005 380
Extending higher dosage of etanercept found safe. Wendling, Patrice Nov 1, 2005 523
Fumaric acid esters from Germany may offer help in severe psoriasis. Walsh, Nancy Nov 1, 2005 560
Biologic therapies may tackle palmoplantar pustular psoriasis. Wendling, Patrice Nov 1, 2005 418
Extending higher dosage of etanercept found safe: some prescribers may keep patients on a regimen in order to maintain insurance coverage of the drug. Wendling, Patrice Nov 1, 2005 522
Biologic therapies tackle palmoplantar pustulosis. Wendling, Patrice Nov 1, 2005 439
Infliximab benefits lasting in plaque psoriasis: visible psoriasis was absent in 26% of patients; 47% had no significant impact on social life or activities. Walsh, Nancy Sep 1, 2005 527
Development pipeline filled with oral psoriasis therapies. Wendling, Patrice Sep 1, 2005 561
Promising oral psoriasis drugs are in pipeline. Wendling, Patrice Aug 15, 2005 568
Psoriasis therapies: striking a balance. Koo, John Y.M. Editorial Jul 1, 2005 548
Sequential therapy is one way to go in psoriasis. Sullivan, Michele G. Jul 1, 2005 620
Adalimumab looks good for psoriasis. Sullivan, Michele G. Jun 1, 2005 510
Infliximab boosts therapy for psoriatic spondyloarthropathy. May 15, 2005 354
Sequential therapy is way to go in psoriasis: after the combo achieves good control, the plan should downshift, eliminating the more toxic agent. Sullivan, Michele G. May 1, 2005 610
Biologic agents for psoriasis. Zoler, Mitchel L.; Kirn, Timothy F. Apr 1, 2005 1490
Psoriasis responds to intermittent etanercept. Boschert, Sherry Mar 1, 2005 591
Psoriasis may respond to intermittent etanercept. Boschert, Sherry Mar 1, 2005 592
Psoriasis flare unpredictable but manageable. Brunk, Doug Brief Article Feb 15, 2005 221
Two cytokines overexpressed in psoriasis. Bates, Betsy Brief Article Jan 1, 2005 257
Wide number of biologics for psoriasis complicates therapy. Finn, Robert Dec 1, 2004 485
Intensive insulin Tx may kick-start pancreas in adolescents with diabetes. Johnson, Kate Dec 1, 2004 605
Efalizumab effective for at least 2 years. Evans, Jeff Brief Article Dec 1, 2004 265
Tazarotene deemed 'nonapprovable' for psoriasis: risk management plans, noninferiority data, and chance of off-label uses were among FDA's concerns. Mechcatie, Elizabeth Nov 15, 2004 1011
New drug relieves psoriasis. Oct 1, 2004 244
Tuberculosis testing is essential before starting anti-TNF therapy. Johnson, Kate Sep 1, 2004 384
Psoriasis patients can have at-home care with new Tx: enbrel approved. Splete, Heidi Jul 15, 2004 469
Long-term efalizumab effective in severe psoriasis. Evans, Jeff Jul 1, 2004 394
Enbrel's approval offers psoriasis care at home. Splete, Heidi Jun 15, 2004 550
Biologics aren't the only approach for expanding psoriasis Tx options. Worcester, Sharon Jun 15, 2004 551
FDA okays biotech psoriasis treatment. Nov 24, 2003 370
Efalizumab may be next biologic agent for psoriasis: FDA advisory panel gives ok. Mechcatie, Elizabeth Product/Service Evaluation Nov 1, 2003 748
FDA reviews fixed topical combo for psoriasis: potential first-line TX. (treatment). Goldman, Erik L. Product/Service Evaluation Nov 1, 2003 316
FDA reviews fixed topical combo of vitamin D analogue, steroid: psoriasis therapy. Goldman, Erik Oct 1, 2003 519
Oral tazarotene helps clear psoriasis: potential mate for methotrexate. Bates, Betsy Oct 1, 2003 433
Efalizumab likely to be next biologic treatment for psorasis: FDA advisory panel gives ok. Mechcatie, Elizabeth Oct 1, 2003 768
Topical tacrolimus ideal for facial, eyelid psoriasis; alternative to steroids. Goldman, Erik Oct 1, 2003 579
2003 FDA drug approvals. Brief Article Jul 1, 2003 212
Topiramate clears psoriasis in mood disorder patients. (Study of Seven Patients). Kirn, Timothy F. May 1, 2003 384
Skin conditions provide clues for HIV treatment. (When to Start, Stop, and Change Meds). Finn, Robert Apr 15, 2003 630
New & Approved: Pegasys/Copegus * Amevive. Mechcatie, Elizabeth Mar 15, 2003 674
Study shows BioTie's new treatment helps psoriasis patients. Brief Article Mar 1, 2002 230
SKYEPHARMA ACQUIRES STAKE IN ASTRALIS. Brief Article Dec 19, 2001 143
Infliximab Cut Psoriasis Severity Score by 75%. MANN, ARNOLD Product/Service Evaluation Sep 15, 2001 309
Arthritis drug succeeds vs. psoriasis. N.S. Brief Article Jul 14, 2001 336
Topical Cream Regulates Skin Cell Growth. MOON, MARY ANN Brief Article Jun 1, 2001 325
Twice-Daily Foam Can Improve Body Psoriasis. BATES, BETSY May 1, 2000 406
Clobetasol Propionate Foam Reduced Scalp Psoriasis. May 1, 2000 162
Topical Calcipotriol, Methotrexate Gel Treat Scalp Psoriasis. BOSCHERT, SHERRY May 1, 2000 400
Miralex OTC Skin Cream Contains Potent Steroid. Feb 15, 2000 235
Tazarotene for psoriasis. Nov 1, 1997 90

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |